13 In 1993, The Journal of Clinical Apheresis published a paper detailing the use of TPE as either a first- or second-line therapy to be used with other modalities on disorders such as Raynauds disease, systemic lupus erythematosus, coagulation factor inhibitors, familial hypercholesterolemia, acute Guillain-Barr syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, cryoglobulinemia, Goodpastures syndrome, and thrombotic thrombocytopenic purpura
Weight loss is big business, which makes some doctors pretend theyre hesitant to openly share their weight loss secrets and discoveries
Ready to Take the Next Step in your Wellness Journey
When I briefly posted last week about the LIVV company and free NAD+ shots on X, I got backlash from several longevity doctors who prescribe peptides in their medical practice